Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seletracetam in refractory epilepsy
NCT00175864Phase 3Withdrawn
- Sponsor
- UCB
- Start
- Feb 2006
- Modality
- Small Molecules
01
Overview
Phase 3, open-label trial of seletracetam in epilepsy, sponsored by UCB. Primary endpoint: Safety profile of seletracetam. Planned start Feb 2006; status: withdrawn.
02
Drugs
seletracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00175864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175864.